Carlos Gómez Alonso-rekin lankidetzan egindako argitalpenak (8)

2023

  1. Long-Term Treatment and Effect of Discontinuation of Calcifediol in Postmenopausal Women with Vitamin D Deficiency: A Randomized Trial

    Journal of Bone and Mineral Research, Vol. 38, Núm. 4, pp. 471-479

2022

  1. Executive summary clinical practice guideline of postmenopausal, glucocorticoid-induced, and male osteoporosis (2022 update)

    Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 1, pp. 5-12

  2. Reply to Calcifediol Is Not Superior to Cholecalciferol in Improving Vitamin D Status in Postmenopausal Women

    Journal of Bone and Mineral Research

2021

  1. Calcifediol is superior to cholecalciferol in improving vitamin D status in postmenopausal women: a randomized trial

    Journal of Bone and Mineral Research, Vol. 36, Núm. 10, pp. 1967-1978

2019

  1. The next step after anti-osteoporotic drug discontinuation: an up-to-date review of sequential treatment

    Endocrine, Vol. 64, Núm. 3, pp. 441-455

2006

  1. Inhaled Steroids Do Not Decrease Bone Mineral Density But Increase Risk of Fractures: Data from the GIUMO Study Group

    Journal of Clinical Densitometry, Vol. 9, Núm. 2, pp. 154-158

2005

  1. Características clínicas y factores de riesgo de la osteoporosis en mujeres posmenopáusicas afectas de fractura de colles: el estudio GIUMO

    Revista Española de Enfermedades Metabólicas Oseas, Vol. 14, Núm. 2, pp. 23-28

  2. Postmenopausal women with Colles' fracture have lower values of bone mineral density than controls as measured by quantitative ultrasound and densitometry

    Journal of Clinical Densitometry, Vol. 8, Núm. 4, pp. 430-435